(Total Views: 246)
Posted On: 05/11/2020 12:22:38 PM
Post# of 102837
$BKLLF / $CODE Company Has Secured Rights to Innovative Transdermal Delivery for Hydroxychloroquine Which Is Anticipated to Reduce Side Effects and Improve Outcomes
VANCOUVER, BC / ACCESSWIRE / May 11, 2020 / Codebase Ventures Inc. ("Codebase" or the "Company"
(CODE.CN)(C5B.F)(BKLLF) an investment company, wishes to provide an update on its strategy toward the development of a transdermal delivery system for hydroxychloroquine.
https://seekingalpha.com/pr/17866493-codebase...e-strategy
$WRHLF
VANCOUVER, BC / ACCESSWIRE / May 11, 2020 / Codebase Ventures Inc. ("Codebase" or the "Company"
(CODE.CN)(C5B.F)(BKLLF) an investment company, wishes to provide an update on its strategy toward the development of a transdermal delivery system for hydroxychloroquine. https://seekingalpha.com/pr/17866493-codebase...e-strategy
$WRHLF
(0)
(0)
